| URL | https://www.wsj.com/articles/former-pittsburgh-ste |
| Source | Wall Street Journal |
| Date Published | 11/17/2021 |
| Author Name | Kris Maher |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Pitt BioForge |
| Parent company | Pitt BioForge |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2022 |
| Capital investment ($): | 100 |
| City reshored to: | Pittsburgh |
| State(s) reshored to: | PA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | gene therapy |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Infrastructure, Image/brand, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Under-utilized capacity |